Codexis Inc., a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Axolabs, an oligonucleotide Contract Research Development and Manufacturing organization (CRDMO), have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis Manufacturing Platform. This partnership provides Axolabs access to an innovative, scalable RNA manufacturing solution powered by enzymatic synthesis. The agreement also paves the way for future licensing...